FDA.reportPublic FDA data

METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A

Substance profile for UNII NX76LV5T8J, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Substance Identity#

UNII
NX76LV5T8J
Preferred term
METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A
Registry number
25212-88-8
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
Polymer substance not supported

Chemical And Database Identifiers#

RxCUI
1309718
PubChem
0
NCIt
C83949
INN ID
0

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
RxNorm1309718mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=1309718
NCI ThesaurusC83949ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C83949
FDA Substance Registration SystemNX76LV5T8Jprecision.fda.gov/uniisearch/srs/unii/NX76LV5T8J

DailyMed Socrata Ingredients#

DailyMed label, SPL version table
DailyMed labelSPL version
These highlights do not include all the information needed to use tamsulosin hydrochloride capsules safely and effectively. See full prescribing information for tamsulosin hydrochloride capsules. TAMSULOSIN hydrochloride capsules USP, 0.4 mg for oral use Initial U.S. Approval: 19976
These highlights do not include all the information needed to use bupropion hydrochloride extended-release tablets (XL) safely and effectively. See full prescribing information for bupropion hydrochloride extended-release tablets (XL). BuPROPion Hydrochloride Extended-Release Tablets USP, for oral use Initial U.S. Approval: 19851
PANTOPRAZOLE SODIUM2
PANTOPRAZOLE SODIUM5
Diclofenac Sodium and Misoprostol Delayed-Release Tablets1
Diclofenac Sodium Delayed-release Tablets USP, 25 mg, 50 mg and 75 mg2
Diclofenac Sodium Delayed-release Tablets USP, 25 mg, 50 mg and 75 mg1
DIVALPROEX SODIUM2
BUPROPION HYDROCHLORIDE2
These highlights do not include all the information needed to use duloxetine delayed-release capsules, USP safely and effectively. See full prescribing information for duloxetine delayed-release capsules, USP. DULOXETINE delayed-release capsules USP, for oral use. Initial U.S. Approval: 20047
Omeprazole DR2
Naproxen Delayed-release Tablets USP, 375 mg and 500 mg2
Paroxetine Hydrochloride Controlled-Release Tablets1000
These highlights do not include all the information needed to use PREVACID safely and effectively. See full prescribing information for Prevacid: PREVACID (lansoprazole) delayed-release capsules, for oral use PREVACID SoluTab (lansoprazole) delayed-release orally disintegrating tablets, for oral use Initial U.S. Approval: 19951000
These highlights do not include all the information needed to use PANTOPRAZOLE sodium delayed-release tablets, USP safely and effectively. See full prescribing information for PANTOPRAZOLE sodium delayed-release tablets, USP. PANTOPRAZOLE sodium delayed-release tablets, USP, for oral administration Initial U.S. approval: 200011
These highlights do not include all the information needed to use OMEPRAZOLE delayed-release capsules, USP safely and effectively. See full prescribing information for OMEPRAZOLE delayed-release capsules, USP. OMEPRAZOLE Delayed-Release Capsules, USP, for oral use INITIAL U.S. APPROVAL: 19894
These highlights do not include all the information needed to use bupropion hydrochloride extended-release tablets (XL) safely and effectively. See full prescribing information for bupropion hydrochloride extended-release tablets (XL). Bupropion Hydrochloride Extended-Release Tablets, USP (XL) for oral use Initial U.S. Approval: 19853
PRESCRIBING INFORMATION BuPROPion Hydrochloride Extended-Release Tablets (XL) Revised: August 2010 Rx only 174662-34
These highlights do not include all the information needed to use OMEPRAZOLE delayed-release capsules, USP safely and effectively. See full prescribing information for OMEPRAZOLE delayed-release capsules, USP. OMEPRAZOLE Delayed-Release Capsules, USP, for oral use INITIAL U.S. APPROVAL: 19892
Morphine Sulfate Extended-release Capsules, USP Revised: May 2011 CII Rx only 1985282
These highlights do not include all the information needed to use esomeprazole magnesium delayed-release capsules USP safely and effectively. See full prescribing information for esomeprazole magnesium delayed-release capsules USP. ESOMEPRAZOLE MAGNESIUM delayed-release capsules USP, for oral use Initial U.S. Approval: 1989 (omeprazole)2
These highlights do not include all the information needed to use omeprazole safely and effectively. See full prescribing information for omeprazole. OMEPRAZOLE delayed-release capsules USP, for oral use INITIAL U.S. APPROVAL: 19891
These highlights do not include all the information needed to use pantoprazole sodium delayed-release tablets safely and effectively. See full prescribing information for pantoprazole sodium delayed-release tablets. PANTOPRAZOLE sodium delayed-release tablets USP, for oral administration Initial U.S. approval: 20002
These highlights do not include all the information needed to use pantoprazole sodium delayed-release tablets USP safely and effectively. See full prescribing information for pantoprazole sodium delayed-release tablets USP. PANTOPRAZOLE Sodium delayed-release tablets USP for oral use Initial U.S. approval: 20001
These highlights do not include all the information needed to use OMEPRAZOLE delayed-release capsules, USP safely and effectively. See full prescribing information for OMEPRAZOLE delayed-release capsules, USP . OMEPRAZOLE Delayed-Release Capsules, USP , for oral use INITIAL U.S. APPROVAL: 198915
These highlights do not include all the information needed to use divalproex sodium delayed-release tablets, USP safely and effectively. See full prescribing information for divalproex sodium delayed-release tablets, USP. DIVALPROEX sodium delayed-release tablets, USP for oral use Initial U.S. Approval: 19831
These highlights do not include all the information needed to use DIVALPROEX Sodium Delayed-Release Tablets, USP safely and effectively. See full prescribing information for DIVALPROEX Sodium Delayed-Release Tablets, USP DIVALPROEX Sodium Delayed-Release Tablets, USP for Oral use Initial U.S. Approval: 19831
These highlights do not include all the information needed to use Divalproex Sodium Delayed Release Tablets safely and effectively. See full prescribing information for Divalproex Sodium Delayed Release Tablets. Divalproex Sodium Delayed Release Tablets USP for Oral use. Initial U.S. Approval: 19831
These highlights do not include all the information needed to use Pantoprazole Sodium Delayed-Release Tablets USP safely and effectively. See full prescribing information for Pantoprazole Sodium Delayed-Release Tablets USP. PANTOPRAZOLE Sodium Delayed-Release Tablets USP for oral use Initial U.S. Approval: 20002
These highlights do not include all the information needed to use Divalproex Sodium Delayed-Release Tablets, USP safely and effectively. See full prescribing information for Divalproex Sodium Delayed-Release Tablets, USP Divalproex Sodium Delayed-Release Tablets, USP for Oral use Initial U.S. Approval: 198314
Aspirin EC 81 mg17
These highlights do not include all the information needed to use OMEPRAZOLE delayed-release capsules, USP safely and effectively. See full prescribing information for OMEPRAZOLE delayed-release capsules, USP . OMEPRAZOLE Delayed-Release Capsules, USP , for oral use INITIAL U.S. APPROVAL: 19891
Diclofenac Sodium Delayed-release Tablets USP, 25 mg, 50 mg and 75 mg6
These highlights do not include all the information needed to use omeprazole safely and effectively. See full prescribing information for omeprazole. OMEPRAZOLE DELAYED-RELEASE CAPSULES, USP INITIAL U.S. APPROVAL: 19892
These highlights do not include all the information needed to use duloxetine delayed-release capsules, USP safely and effectively. See full prescribing information for duloxetine delayed-release capsules, USP. DULOXETINE delayed-release capsules USP, for oral use. Initial U.S. Approval: 20042
Enteric Coated Aspirin Regular Strength1
These highlights do not include all the information needed to use pantoprazole sodium safely and effectively. See full prescribing information for pantoprazole sodium delayed-release tablets. Pantoprazole Sodium Delayed-Release Tablets, USP Initial U.S. approval: 20001
Aspirin Tablets (NSAID) * nonsteroidal anti-inflammatory drug1001
These highlights do not include all the information needed to use pantoprazole sodium delayed-release tablets USP safely and effectively. See full prescribing information for pantoprazole sodium delayed-release tablets USP. PANTOPRAZOLE sodium delayed-release tablets USP for oral use Initial U.S. Approval: 20001001
Diclofenac sodium and misoprostol delayed-release tablets3
These highlights do not include all the information needed to use divalproex sodium extended-release tablets USP safely and effectively. See full prescribing information for divalproex sodium extended-release tablets USP. DIVALPROEX Sodium Extended-Release Tablets USP, for Oral Use Initial U.S. Approval: 20002
These highlights do not include all the information needed to use Duloxetine Delayed-release Capsules safely and effectively. See full prescribing information for Duloxetine Delayed-release Capsules. DULOXETINE delayed-release capsules USP for oral use. Initial U.S. Approval: 20042
These highlights do not include all the information needed to use OMEPRAZOLE delayed-release capsules, USP safely and effectively. See full prescribing information for OMEPRAZOLE delayed-release capsules, USP. OMEPRAZOLE Delayed-Release Capsules, USP, for oral use INITIAL U.S. APPROVAL: 19892
These highlights do not include all the information needed to use Pantoprazole Sodium Delayed-Release Tablets safely and effectively. See full prescribing information for Pantoprazole Sodium Delayed-Release Tablets. PANTOPRAZOLE SODIUM delayed-release tablets Initial U.S. approval: 20001
These highlights do not include all the information needed to use Pantoprazole Sodium Delayed-Release Tablets safely and effectively. See full prescribing information for Pantoprazole Sodium Delayed-Release Tablets. PANTOPRAZOLE SODIUM delayed-release tablets Initial U.S. approval: 20003
These highlights do not include all the information needed to use safely and effectively. See full prescribing information for . Initial U.S. Approval: 1997 budesonide capsules (enteric coated) budesonide capsules (enteric coated) BUDESONIDE capsules (enteric coated), for oral use2
Divalproex Sodium Delayed Release Tablets USP1
These highlights do not include all the information needed to use omeprazole safely and effectively. See full prescribing information for omeprazole. OMEPRAZOLE DELAYED-RELEASE CAPSULES, USP Initial U.S. Approval: 19891
NAPROXEN DELAYED-RELEASE TABLETS USP 1005 1006 Rx only1
Venlafaxine Hydrochloride Extended-Release Capsules Rx only3
These highlights do not include all the information needed to use lansoprazole delayed-release capsules safely and effectively. See full prescribing information for: LANSOPRAZOLE delayed-release capsules USP For oral administration Initial U.S. Approval: 19951
These highlights do not include all the information needed to use Omeprazole safely and effectively. See full prescribing information for Omeprazole. Omeprazole (Omeprazole) CAPSULE for ORAL use. Initial U.S. Approval: 20133
These highlights do not include all the information needed to use PANTOPRAZOLE SODIUM safely and effectively. See full prescribing information for PANTOPRAZOLE SODIUM. PANTOPRAZOLE SODIUM (PANTOPRAZOLE SODIUM) TABLET for ORAL use. Initial U.S. Approval: 20073
DIVALPROEX SODIUM DELAYED-RELEASE TABLETS1
These highlights do not include all the information needed to use metoprolol succinate extended-release tablets safely and effectively. See full prescribing information for metoprolol succinate extended-release tablets. Metoprolol Succinate Extended-Release Tablets, USP for Oral use. "Initial U.S. Approval:199220
Bupropion Hydrochloride Extended-Release Tablets USP (XL)1
DRUG FACTS1
Drug Facts1
FERROUS SULFATE ENTERIC-COATED TABLETS3
Unknown Title1
These highlights do not include all the information needed to use metoprolol succinate extended-release tablets safely and effectively. See full prescribing information for metoprolol succinate extended-release tablets. Metoprolol Succinate Extended-Release Tablets, USP for Oral Use INITIAL U.S. APPROVAL: 19925
Diclofenac Sodium Delayed-release Tablets USP, 25 mg, 50 mg and 75 mg1
These highlights do not include all the information needed to use omeprazole safely and effectively. See full prescribing information for omeprazole. OMEPRAZOLE DELAYED-RELEASE CAPSULES, USP INITIAL U.S. APPROVAL: 19892
These highlights do not include all the information needed to use tamsulosin hydrochloride safely and effectively. See full prescribing information for tamsulosin hydrochloride capsules. Tamsulosin Hydrochloride Capsules USP, 0.4 mg Initial U.S. Approval: 19971
DRUG FACTS2
Aspirin EC Tablets, 81 mg1
PRESCRIBING INFORMATION BuPROPion Hydrochloride Extended-Release Tablets (XL)3
These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 19953
Aspirin NSAIDS EC Tablet 325mg- 5gr9
Aspirin Tablets (NSAID) * nonsteroidal anti-inflammatory drug3
DRUG FACTS1
Diclofenac Sodium Delayed-release Tablets, USP2
FERROUS SULFATE ENTERIC-COATED TABLETS2
These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 19953
These highlights do not include all the information needed to use tamsulosin hydrochloride safely and effectively. See full prescribing information for tamsulosin hydrochloride capsules. Tamsulosin Hydrochloride Capsules USP, 0.4 mg Initial U.S. Approval: 19972
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use omeprazole safely and effectively. See full prescribing information for omeprazole. OMEPRAZOLE DELAYED-RELEASE CAPSULES, USP "Initial U.S. Approval:".19896
These highlights do not include all the information needed to use lansoprazole delayed-release capsules safely and effectively. See full prescribing information for: LANSOPRAZOLE delayed-release capsules USP For oral administration Initial U.S. Approval: 19951
These highlights do not include all the information needed to use omeprazole safely and effectively. See full prescribing information for omeprazole. OMEPRAZOLE DELAYED-RELEASE CAPSULES, USP Initial U.S. Approval: 19891
Drug Facts1
Unknown Title1
These highlights do not include all the information needed to use lamotrigine extended-release tablets safely and effectively. See full prescribing information for lamotrigine extended-release tablets. Lamotrigine Extended-Release Tablets Initial U.S. Approval: 19941
WELLBUTRIN XL ® (bupropion hydrochloride extended-release tablets)1
Drug Facts2
NAPROXEN DELAYED-RELEASE TABLETS USP 1006 Rx only1
These highlights do not include all the information needed to use tamsulosin hydrochloride capsules USP safely and effectively. See full prescribing information for tamsulosin hydrochloride capsules USP. TAMSULOSIN HYDROCHLORIDE capsules USP for oral use Initial U.S. Approval: 19971
Ecotrin Low Strength2
Diclofenac Sodium Delayed-release Tablets, USP 50 mg1
These highlights do not include all the information needed to use lansoprazole delayed-release capsules USP safely and effectively. See full prescribing information for lansoprazole delayed-release capsules USP. LANSOPRAZOLE delayed-release capsules USP for oral use Initial U.S. Approval: 19951
Diclofenac Sodium Delayed-release Tablets USP, 25 mg, 50 mg and 75 mg3
Omeprazole Delayed-Release Capsules These highlights do not include all the information needed to use. See full prescribing information for. Initial U.S. Approval:1
Omeprazole Delayed-Release Capsules These highlights do not include all the information needed to use. See full prescribing information for. Initial U.S. Approval:1
Drug Facts1
DRUG FACTS1
These highlights do not include all the information needed to use DEXILANT safely and effectively. See full prescribing information for DEXILANT. DEXILANT (dexlansoprazole) delayed-release capsules, for oral use Initial U.S. Approval: 1995 (lansoprazole)2
Naproxen Delayed-release Tablets USP, 375 mg and 500 mg1
These highlights do not include all the information needed to use pantoprazole sodium safely and effectively. See full prescribing information for pantoprazole sodium delayed-release tablets. Pantoprazole Sodium Delayed-Release Tablets, USP Initial U.S. approval: 20001
These highlights do not include all the information needed to use lansoprazole delayed-release capsules USP safely and effectively. See full prescribing information for lansoprazole delayed-release capsules USP. LANSOPRAZOLE delayed-release capsules USP for oral use Initial U.S. Approval: 19954
These highlights do not include all the information needed to use pantoprazole sodium delayed-release tablets USP safely and effectively. See full prescribing information for pantoprazole sodium delayed-release tablets USP. PANTOPRAZOLE sodium delayed-release tablets USP for oral use Initial U.S. Approval: 20002
Omeprazole Delayed-Release Capsules These highlights do not include all the information needed to use See full prescribing information for use INITIAL U.S. APPROVAL: 20072
Diclofenac Sodium Delayed-release Tablets USP, 25 mg, 50 mg and 75 mg1
These highlights do not include all the information needed to use Lansoprazole Delayed-Release Capsules and Lansoprazole Delayed-Release Orally Disintegrating Tablets safely and effectively. See full prescribing information for: Lansoprazole Delayed-Release Capsules Lansoprazole Delayed-Release Orally Disintegrating Tablets For oral administration Initial U.S. Approval: 19952
NAPROXEN DELAYED-RELEASE TABLETS USP 1005 1006 Rx only1
DRUG FACTS1
These highlights do not include all the information needed to use tamsulosin hydrochloride capsules safely and effectively. See full prescribing information for tamsulosin hydrochloride capsules. Tamsulosin Hydrochloride Capsules, 0.4 mg Initial U.S. Approval: 19973
Bisacodyl USP 5 mg Laxative3
PAXIL CR ® (paroxetine hydrochloride) Controlled-Release Tablets1
These highlights do not include all the information needed to use PROTONIX safely and effectively. See full prescribing information for PROTONIX. PROTONIX (pantoprazole sodium) delayed-release tablets PROTONIX (pantoprazole sodium) for delayed-release oral suspension Initial U.S. approval: 20001
21b3b8a2-bfed-4945-954d-6a42ea61888f3
ASPIRIN ENTERIC COATED YELLOW TABLETS, 81 mg1
ASPIRIN ENTERIC COATED ORANGE TABLETS, 325 mg1
Divalproex Sodium Delayed-Release Tablets, USP Rx only1
These highlights do not include all the information needed to use pantoprazole sodium delayed-release tablets, USP safely and effectively. See full prescribing information for pantoprazole sodium delayed-release tablets, USP. Pantoprazole Sodium Delayed-Release Tablets, USP Initial U.S. approval: 20002
NAPROXEN DELAYED-RELEASE TABLETS Rx only1
Omeprazole 20 mg1
Aspirin 81 mg Pain reliever3
These highlights do not include all the information needed to use pantoprazole sodium delayed-release tablets USP safely and effectively. See full prescribing information for pantoprazole sodium delayed-release tablets USP. PANTOPRAZOLE sodium delayed-release tablets USP for oral use Initial U.S. Approval: 20001
These highlights do not include all the information needed to use PROTONIX safely and effectively. See full prescribing information for PROTONIX. PROTONIX (pantoprazole sodium) delayed-release tablets PROTONIX (pantoprazole sodium) for delayed-release oral suspension Initial U.S. approval: 20001
WELLBUTRIN XL ® (bupropion hydrochloride extended-release tablets)1
PAXIL CR ® (paroxetine hydrochloride) Controlled-Release Tablets1
These highlights do not include all the information needed to use lansoprazole delayed-release orally disintegrating tablets safely and effectively. See full prescribing information for lansoprazole delayed-release orally disintegrating tablets. LANSOPRAZOLE delayed-release orally disintegrating tablets for oral use Initial U.S. Approval: 19951

Inactive Ingredient Database#

Browse recovered IID releases and source provenance.

Current IID rows for UNII NX76LV5T8J page 1 of 1 · 13 matching rows.

Ingredient, UNII, CAS table
IngredientUNIICASDosage formRoutePotencyMaximum daily exposure
METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE ANX76LV5T8J25212888CAPSULEORAL245 mg
METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE ANX76LV5T8J25212888CAPSULE, COATEDORAL56 mg
METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE ANX76LV5T8J25212888CAPSULE, COATED PELLETSORAL32 mg
METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE ANX76LV5T8J25212888CAPSULE, DELAYED RELEASEORAL1321 mg
METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE ANX76LV5T8J25212888CAPSULE, DELAYED RELEASE PELLETSORAL1494 mg
METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE ANX76LV5T8J25212888CAPSULE, EXTENDED RELEASEORAL283 mg
METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE ANX76LV5T8J25212888GRANULE, FOR SUSPENSIONORAL1250 mg
METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE ANX76LV5T8J25212888SUSPENSIONORAL1306 mg
METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE ANX76LV5T8J25212888TABLETORAL489 mg
METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE ANX76LV5T8J25212888TABLET, DELAYED RELEASEORAL1500 mg
METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE ANX76LV5T8J25212888TABLET, EXTENDED RELEASEORAL403 mg
METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE ANX76LV5T8J25212888TABLET, ORALLY DISINTEGRATINGORAL20 mg
METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE ANX76LV5T8J25212888TABLET, ORALLY DISINTEGRATING, DELAYED RELEASEORAL570 mg